At a glance
- Originator Pfizer
- Class Antipsychotics; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 19 Oct 2000 Profile reviewed but no significant changes made
- 07 Feb 1997 No-Development-Reported for Psychotic disorders in USA (Unknown route)